Cannabis
ZYUS
Recorded March 5, 2025
ZYUS Life Sciences (CVE: ZYUS) has developed a new compound that treats chronic pain effectively without opioids.
ZYUS Life Sciences (CVE: ZYUS) has developed a new compound that treats chronic pain effectively without opioids.
The company’s AI-powered drug development program has the potential to uncover treatments for multiple diseases and impact millions of lives.
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
A functional beverage company and CPG accelerator that recently purchased Yerbaé, to help its customers live healthier and happier.
Alzheon is a clinical-stage biopharma company with a first-in-class oral treatment targeting the root cause of Alzheimer’s disease.
Ingenious, patented micro-hydroelectric energy recovery system produces renewable energy from the water that flows through municipal pipes
Heritage is the first publicly traded craft distillery in the United States and the most awarded craft distillery 10 years in a row
The only publicly traded business accelerator and holding company in the U.S. for Nordic life science companies.
A clinical-stage precision medicine company enhancing patient outcomes through improved decision-making and personalized cancer care.
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
OncoOne has created a diverse pipeline of treatment options for solid tumor cancers as well as inflammatory diseases including rheumatoid arthritis
India is the world’s fifth largest economy with an innovative culture that is creating substantial investment opportunities right now.